611 filings
4
Sapirstein James
3 Apr 24
First Wave BioPharma / JAMES SAPIRSTEIN ownership change
5:14pm
4
Romano Sarah
3 Apr 24
First Wave BioPharma / Sarah Romano ownership change
5:13pm
10-K
2023 FY
FWBI
First Wave BioPharma Inc
Annual report
29 Mar 24
4:16pm
8-K
FWBI
First Wave BioPharma Inc
22 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
4
FWBI
First Wave BioPharma Inc
19 Mar 24
First Wave BioPharma / JAMES SAPIRSTEIN ownership change
4:13pm
4
qb19d n0s8elscth9
19 Mar 24
First Wave BioPharma / Sarah Romano ownership change
4:10pm
8-K
wrij oksmcah64y
18 Mar 24
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
4:40pm
DEFA14A
3hlyd0twzid
18 Mar 24
Additional proxy soliciting materials
4:31pm
4
31n1ipth3v5xlvq
15 Mar 24
First Wave BioPharma / Jack Syage ownership change
6:05pm
4
nrpv0z7q
15 Mar 24
First Wave BioPharma / CHAITAN PHD KHOSLA ownership change
6:05pm
3
quei mj7hq
15 Mar 24
First Wave BioPharma / CHAITAN PHD KHOSLA ownership change
6:00pm
3
joe kfwwb9
15 Mar 24
First Wave BioPharma / Jack Syage ownership change
6:00pm
DEFA14A
2xazhwugbv9i3zz mqw0
14 Mar 24
Additional proxy soliciting materials
6:10am
8-K
kbc3qn0vu4
14 Mar 24
Latiglutenase is a potentially first-in-class oral biotherapeutic for the treatment of celiac disease
6:09am
8-K
3vjh3q wg46np
5 Mar 24
First Wave BioPharma, Inc. to raise approximately $4.0 million of Gross Proceeds in Registered Direct Offering
5:26pm
424B5
w5upz9cq4rk8 qsr
4 Mar 24
Prospectus supplement for primary offering
5:29pm
SC 13G/A
u36z4c h5
14 Feb 24
First Wave BioPharma / ARMISTICE CAPITAL ownership change
2:45pm
424B3
7ukeyr27
18 Jan 24
Prospectus supplement
4:01pm
EFFECT
12rs oy8t0udse
18 Jan 24
Notice of effectiveness
12:15am
4
v12993h8 yw5e3w
17 Jan 24
First Wave BioPharma / Sarah Romano ownership change
4:02pm